1.7 billion people. One coordination failure.
Musculoskeletal conditions are the single largest contributor to disability worldwide — roughly one in six of all years lived with disability. The burden falls hardest on less research-intensive regions of Europe, many of them COST Inclusiveness Target Countries that carry the highest rates while remaining least connected to the field’s emerging science.
A new generation of regenerative therapies is advancing fast — but the field is fragmented and inconsistently defined, with no shared classification, no agreed outcome standard, no European quality benchmark and no coordinated training route. Evidence cannot be pooled, effort is duplicated, and unproven treatments compete on equal footing with evidence-based ones. This is a coordination failure no single research project can solve.
Preserve. Repair. Regenerate. Before replace.
Repair and regeneration are points on the same biological continuum: repair restores the integrity of injured tissue; regeneration restores its structure and function. The body does both remarkably well — a marathon runner’s calf recovers in 24–48 hours — but when degeneration outpaces healing, replacement becomes the default. IAMRegen’s ambition is to shift the balance of care up the pathway, so stimulating the body’s own capacity reduces the need to replace the joint.
Eight objectives. Two engines.
The barrier is coordination, not discovery.
The knowledge, techniques and expert groups already exist across Europe. What is missing is a shared framework, comparable evidence, agreed standards and a route for people and knowledge to move between centres — networking problems by definition. A pan-European COST Action funds exactly this: consensus, common standards, training, mobility and dissemination.
COST funds the networking, not the research — so partners join and benefit at no research cost to their institution. The consortium is built to COST eligibility: at least seven COST Full or Cooperating Members, at least half from Inclusiveness Target Countries, and at least 40% Young Researchers and Innovators.
Five meetings, one growing Action.
From a founding meeting at the Royal Society of Medicine to an international association — Torino 2027 is our fifth annual meeting.




About I AM Regen.
What is I AM Regen?
I AM Regen is the International Association of Musculoskeletal Regeneration — a global, member-led movement of clinicians, scientists and centres advancing regenerative medicine for the musculoskeletal system. The International Association of Musculoskeletal Regeneration (I AM Regen) exists to take regeneration from principle to standard of care.
Read more about I AM Regen →Who leads the International Association of Musculoskeletal Regeneration?
I AM Regen is led by an executive team: a President (Professor Paul Lee), a President-Elect who also chairs the Scientific Advisory Board (Professor Feza Korkusuz), a Vice-President (Dr. Luminita Labusca), a Congress President and Education Vice-President (Professor Riccardo Ferracini) and a Research & Grants Vice-President who co-chairs the Scientific Advisory Board (Professor Victoria Sarafian).
Meet the executive team →What is the difference between an I AM Regen Member and a Fellow?
Every individual belongs to the International Association of Musculoskeletal Regeneration as a Member. Fellow is a recognition of standing and contribution — Fellows can host visiting fellowships and lead I AM Regen Centres of Excellence. Membership is €100/year and includes Congress entry.
Compare Member & Fellow →How do I join I AM Regen?
Join online as a Member of the International Association of Musculoskeletal Regeneration for €100/year, which includes entry to the annual Congress and a place on the consensus process. Students and junior academics receive a 50% discount on eligible fees.
Join I AM Regen →What is an I AM Regen Centre of Excellence?
An I AM Regen Centre of Excellence is a clinic or laboratory recognised by the International Association of Musculoskeletal Regeneration for meeting its standard in regenerative practice or science. I AM Regen recognises centres — clinical and laboratory — rather than certifying individuals.
Explore Centres of Excellence →When and where is the next I AM Regen Congress?
The 5th Annual Congress of the International Association of Musculoskeletal Regeneration takes place on 12 February 2027 at the Accademia di Medicina in Torino, Italy.
See the Torino 2027 Congress →What is the I AM Regen consensus (Delphi) process?
Each year the International Association of Musculoskeletal Regeneration runs a structured, multi-round Delphi consensus so its members and Fellows can agree international positions on musculoskeletal regeneration, published as a consensus statement.
About the consensus process →What is the I AM Regen Travelling Fellowship?
The I AM Regen Travelling Fellowship connects the association lab to lab and clinic to clinic: a Fellow hosts at their I AM Regen Centre of Excellence and Members apply to visit, learn and collaborate.
About the Travelling Fellowship →

